GREMLIN addresses a fundamental blind spot in mucosal immunology. We know that barrier tissues host highly specialized immune responses, yet we still lack a precise understanding of whether the lymphoid organs that initiate these responses are themselves functionally regionalized, and how such spatial logic is encoded. This knowledge gap limits our ability to precisely modulate immunity induction at mucosal surfaces, where many infections and inflammatory conditions are regulated in a region-specific manner. GREMLIN’s overall objective is to determine whether mucosal-associated lymphoid tissues in the intestine and within the airways form a distributed network with a site-specific “division of labour,” and to identify the cellular niches and local signals that instruct distinct immune outputs in different regions. Among the many receptor systems that regulate immune cell functions, G protein–coupled receptors (GPCRs) are particularly important because they control immune cell positioning, migration and recruitment and enable sensing of local tissue cues; therefore, they are well placed to sustain region-specific immunity and to promote functional immune cell localization within micro-anatomical niches. Accordingly, a key focus is to investigate candidate GPCRs as molecular interpreters of the local tissue environment. GREMLIN also aims to study how microbial and food-derived cues support site-specific mucosal immunity and evaluate whether pathogenic and metabolic inflammation influence such responses. By delivering a mechanistic framework for how region instructs immune induction in health and disease, GREMLIN is expected to set the concepts and fundamental biological knowledge needed for region-specific vaccination or therapeutic strategies. In the longer term, this work aims to help shift mucosal intervention from broadly acting approaches toward a more precise, regionalized paradigm, with interventions tailored to distinct mucosal regions across the gut–lung axis.